The first reports of ivermectin’s anti-cancer properties came in 1995.
Two French researchers found that ivermectin—a Nobel Prize-winning anti-parasite drug—could reverse multidrug resistance in tumors.
- The drug targets tumor stem cells—a driver of cancer tumors and relapses—and promotes cancer death.
- Ivermectin also enhances the effects of chemo and radiation therapy.
- It has a broad impact on the immune system, increasing immune offense against cancers...
No comments:
Post a Comment